Ikarian Capital, LLC Portfolio Holdings

Ikarian Capital, LLC

  • $714 Million
  • Q1 2025

Ikarian Capital, LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $714 Million distributed in 160 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Tarsus Pharmaceuticals, Inc. with a value of $24.9M, Crinetics Pharmaceuticals, Inc. with a value of $17.6M, Spdr S&P 500 ETF Trust with a value of $14M, Sarepta Therapeutics, Inc. with a value of $10.8M, and Blueprint Medicines Corp with a value of $10.1M.

Examining the 13F form we can see an increase of $108M in the current position value, from $606M to 714M.

Ikarian Capital, LLC is based out at Dallas, TX

Below you can find more details about Ikarian Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $714 Million
Healthcare: $512 Million
ETFs: $193 Million
Financial Services: $8.94 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$109M
$4.05 Million 0.57% of portfolio
1,100,000
Q1 2025 New
$74.6M
$3.13 Million 0.44% of portfolio
740,000
Q1 2025 New
$182M
$1.83 Million 0.26% of portfolio
649,534
Q1 2025 Added 12.73%
$254M
$1.64 Million 0.23% of portfolio
358,393
Q1 2025 Added 110.83%
$86.5M
$1.4 Million 0.2% of portfolio
1,217,590
Q1 2025 Added 11.44%
$139M
$1.28 Million 0.18% of portfolio
100,365
Q4 2024 Reduced -0.0%
$78.3M
$1.23 Million 0.17% of portfolio
1,860,179
Q4 2024 New
$103M
$1.17 Million 0.16% of portfolio
950,000
Q4 2024 New
$118M
$1.07 Million 0.15% of portfolio
1,579,528
Q1 2025 Reduced 22.15%
$111M
$851,000 0.12% of portfolio
308,491
Q4 2024 Reduced -0.0%
$207M
$721,000 0.1% of portfolio
191,994
Q1 2025 Added 108.7%
$109M
$719,000 0.1% of portfolio
175,088
Q4 2024 Reduced 0.01%
$123M
$652,000 0.09% of portfolio
1,417,952
Q1 2025 Reduced 8.52%
$187M
$633,000 0.09% of portfolio
136,575
Q1 2025 Reduced 56.17%
$102M
$473,000 0.07% of portfolio
876,037
Q1 2025 Reduced 31.35%
$292M
$469,000 0.07% of portfolio
78,585
Q4 2024 Added 0.01%
$210M
$347,000 0.05% of portfolio
100,000
Q4 2024 New
$118M
$188,000 0.03% of portfolio
55,766
Q4 2024 Reduced 0.16%
$86M
$230,000 0.03% of portfolio
150,900
Q1 2025 Reduced 56.89%
$83.5M
$125,000 0.02% of portfolio
58,526
Q4 2024 Reduced -0.0%
$151M
$145,000 0.02% of portfolio
50,058
Q1 2025 Reduced 94.16%
$180M
$72,000 0.01% of portfolio
14,008
Q1 2025 New
$94.6M
$101,000 0.01% of portfolio
80,071
Q4 2024 Reduced 0.01%

Summary

  • Portfolio
  • No. of Stocks 160
  • Current Value $714 Million
  • Prior Value $606 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 27 stocks
  • Additional Purchases 23 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 30 stocks
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email